Introduction
Cascade reactions are an important way to produce complex organic compounds from simple and readily available components in a 'one-pot' procedure in which two or more successive reactions are carried out as a single transformation [1, 2] . Cascade reactions are especially useful in the synthesis of polycyclic and spiro compounds using modern 'green chemistry' [3] . Thus, the demand for efficient and less labor-intensive methods and the environmental factors are fuelling progress in the cascade reaction strategy [4, 5] .
Recently, 'on-water' [6] [7] [8] and 'on-solvent' [9] [10] [11] methodologies have been suggested to carry out cascade and multicomponent reactions in water or solvent using reagent mixtures and emulsions in the absence of full solubility of components to increase the selectivity and the efficiency of the desired complex synthetic processes. In particular, the concept of 'privileged medicinal structures or scaffolds', is one of the main ideas of drug discovery in last decades [12] .
Barbituric acids (hexahydropyrimidine-2,4,6-triones) are known as a privileged medicinal scaffold, transformations of which lead to important 5-substituted derivatives, the so-called barbiturates. Barbiturates are often used as pharmaceuticals with a wide spectrum of anesthetic and anticonvulsant effects [13, 14] . In recent years, barbiturates have been used in clinical practice as analeptic, anti-AIDS and anticancer agents [15] [16] [17] .
Chromeno [2,3-d] pyrimidines contain both pharmacologically important chromene and pyrimidine moieties. For this class of compounds, a large spectrum of pharmacological properties is known including antitumor, cytotoxic [18] , antioxidant [19] , antiplatelet, antithrombotic [20] and anti-inflammatory activities [21] . Moreover, chromeno [2,3-d] pyrimidines show interesting photophysical properties [22] . Compounds 1 described in this report combine in one molecule hexahydropyrimidine-2,4,6-trione and chromeno [2,3-d] pyrimidine systems, which are part of many biologically active agents.
Few methods are known for the cascade synthesis of chromeno [2,3-d] pyrimidin-5-yl-pyrimidine-2,4,6(1H,3H,5H)-triones 1 (Scheme 1) from salicylaldehydes and barbituric acids. Both bases and acids are known as catalysts for this cascade process. In the presence of piperidine, the reaction of salicylaldehyde with two equivalents of N,N′-dimethylbarbituric acid in boiling ethanol for 5 h furnished compound 1a in a 43% yield [23] . Hydrochloric acid was used as a catalyst in the reaction of salicylaldehyde or 5-bromosalicylaldehyde with N,N′-dimethylbarbituric acid in boiling methanol [24] . A limited, non-catalytic reaction in boiling ethanol has also been described [25] . Recently, an unusual variant of the synthesis of compounds 1 has been suggested by the cascade reaction of a salicylaldehyde and two equivalents of 6-amino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione in the presence of 1,1′-sulfinyldipyridinium bis(hydrogen sulfate) in boiling ethanol for 5-10 h [26] . These methods for the synthesis of compounds 1 have limitations including a low yield, a long reaction time or the requirement of using a non-common catalyst. The successful approach to compounds 1, described in this report, is part of our ongoing research on multicomponent and cascade transformation of C-H acids and carbonyl compounds [27] [28] [29] [30] [31] .
Results and discussion
This report describes a 'one-pot' cascade reaction of a salicylaldehyde 2 and two equivalents of N,N′-dimethylbarbiturate leading to a chromeno [2,3-d] pyrimidin-5-yl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione 1 (Scheme 1). Initially, the cascade transformation of salicylaldehyde 2a and N,N′-dimethylbarbiturate into chromeno[2,3-d]pyrimidine 1a was studied using alcohol emulsions. In a typical experiment, the mixture of salicylaldehyde 2a (3 mmol, 0.37 g) and N,N′-dimethylbarbiturate (6 mmol, 0.94 g) and 3 mL of alcohol was magnetically stirred. In boiling ethanol (78°C) the chromeno [2,3-d] pyrimidine 1a was formed in a 33% yield in 15 min.
The same reaction in boiling n-propanol (97°C) afforded product 1a in a 40% yield. In n-propanol, with NaOAc or KF as a catalyst (10 mol%) product 1a was obtained in a 45% and 48% yield, respectively. The use of LiClO 4 , iodine or HCl as a catalyst resulted in the respective yield of 1a of 53%, 65% and 71%. The yield of 1a increased to 99% for the reaction conducted in n-propanol for 15 min under reflux in the presence of p-TsOH (10 mol%). Decreasing the reaction time to 10 min under otherwise similar conditions resulted in the formation of 1a in a 90% yield. Overall, under optimized conditions, stirring the emulsion of salicylaldehyde 2a-h, N,N′-dimethylbarbiturate and a catalytic amount of p-TsOH in boiling n-propanol for 15 min furnished chromeno [2,3- 
On the basis of these results and the mechanistic data on cascade reactions of carbonyl compounds with barbituric acids published previously [32] [33] [34] , the following mechanism for the cascade reaction of a salicylaldehyde and N,N′-dimethylbarbiturate can be suggested (Scheme 2).
First, the Knoevenagel condensation of salicylaldehyde 2 with N,N′-dimethylbarbiturate generates the intermediate product 3. In the second step, the Michael addition of the second molecule of N,N′-dimethylbarbiturate to the electron deficient compound 3 results in the formation of the adduct 4. Finally, cyclization of the Michael adduct 4 leads to the observed chromeno [2,3- 
Conclusion
A fast (15 min) and highly efficient direct reaction of substituted salicylaldehydes and N,N′-dimethylbarbiturate in boiling n-propanol in the presence p-TsOH as a catalyst into substituted compounds 1 is described. Upon cooling, analytically pure products 1 precipitate directly from the mixture.
Experimental
All melting points were measured with a Gallenkamp melting-point apparatus and are uncorrected. The 1 H (300 MHz) and 13 C (75 MHz) nuclear magnetic resonance (NMR) spectra were recorded in DMSOd 6 using a Bruker Avance II 300 spectrometer at ambient temperature. Infrared (IR) spectra were recorded with a Bruker ALPHA-T Fourier-transform infrared (FT-IR) spectrometer in KBr pellets. Electron ionization (EI) mass spectra were obtained at 70 eV on a Kratos MS-30 spectrometer equipped with a direct inlet system. Electrospray ionization (ESI) high-resolution mass spectrometry (HR-MS) data were measured on a Bruker micrOTOF II instrument.
General procedure
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